Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
Most Medicare Beneficiaries May Pay More for Drugs Under the IRA
Featured Experts: Erin Trish
In The News View All
Reuters
Padula provides insight on how rare disease therapies are influencing new drug pricing trends
Featured Experts: William Padula
STAT
Expanded coverage of GLP-1s is “probably the single most effective policy” for improving public health, Goldman says
Featured Experts: Dana Goldman
The Wall Street Journal
Many firms producing knockoff weight-loss drugs are “pushing the envelope” on legal requirements for compounders, Schiller says
Featured Experts: Lowell Schiller
Healthcare Dive
Sood recommends key PBM reforms in testimony before U.S. Senate panel
Featured Experts: Neeraj Sood
CalMatters
California’s proposal to establish fiduciary duty for PBMs would be an important cost-saving reform, Joyce says
Featured Experts: Geoffrey Joyce
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
